Arrowhead Stock Volatility

ARWR
 Stock
  

USD 33.96  2.76  8.85%   

We consider Arrowhead Pharma very steady. Arrowhead Pharma secures Sharpe Ratio (or Efficiency) of 0.0027, which signifies that the company had 0.0027% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Arrowhead Pharma, which you can use to evaluate the future volatility of the firm. Please confirm Arrowhead Pharma risk adjusted performance of (0.020366), and Mean Deviation of 2.99 to double-check if the risk estimate we provide is consistent with the expected return of 0.0101%.
  
Arrowhead Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Arrowhead daily returns, and it is calculated using variance and standard deviation. We also use Arrowhead's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Arrowhead Pharma volatility.

30 Days Market Risk

Very steady

Chance of Distress

Very Small

30 Days Economic Sensitivity

Slowly supersedes the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Arrowhead Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Arrowhead Pharma at lower prices. For example, an investor can purchase Arrowhead stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Arrowhead Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Arrowhead Pharma

+0.84CMXHFCslPairCorr
+0.9CSLLYCsl Ltd ADRPairCorr

Arrowhead Pharma Market Sensitivity And Downside Risk

Arrowhead Pharma's beta coefficient measures the volatility of Arrowhead stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Arrowhead stock's returns against your selected market. In other words, Arrowhead Pharma's beta of 0.23 provides an investor with an approximation of how much risk Arrowhead Pharma stock can potentially add to one of your existing portfolios.
Arrowhead Pharma exhibits very low volatility with skewness of 0.18 and kurtosis of -0.35. However, we advise investors to further study Arrowhead Pharma technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arrowhead Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arrowhead Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Arrowhead Pharma Demand Trend
Check current 90 days Arrowhead Pharma correlation with market (DOW)

Arrowhead Beta

    
  0.23  
Arrowhead standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  3.71  
It is essential to understand the difference between upside risk (as represented by Arrowhead Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Arrowhead Pharma's daily returns or price. Since the actual investment returns on holding a position in arrowhead stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Arrowhead Pharma.

Using Arrowhead Put Option to Manage Risk

Put options written on Arrowhead Pharma grant holders of the option the right to sell a specified amount of Arrowhead Pharma at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Arrowhead Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Arrowhead Pharma's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Arrowhead Pharma will be realized, the loss incurred will be offset by the profits made with the option trade.

Arrowhead Pharma's PUT expiring on 2022-10-21

   Profit   
Share
       Arrowhead Pharma Price At Expiration  

Current Arrowhead Pharma Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2022-10-21 PUT at $50.0-0.91220.0165152022-10-2116.7 - 21.512.5View
Put
2022-10-21 PUT at $45.0-0.89970.0219552022-10-2111.7 - 16.510.6View
Put
2022-10-21 PUT at $40.0-0.70060.0317782022-10-219.0 - 12.06.35View
Put
2022-10-21 PUT at $35.0-0.59570.0425662022-10-214.5 - 7.56.0View
Put
2022-10-21 PUT at $30.0-0.38750.04441992022-10-210.55 - 5.02.38View
Put
2022-10-21 PUT at $25.0-0.22580.023782022-10-210.1 - 4.00.76View
View All Arrowhead Pharma Options

Arrowhead Pharma Stock Volatility Analysis

Volatility refers to the frequency at which Arrowhead Pharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Arrowhead Pharma's price changes. Investors will then calculate the volatility of Arrowhead Pharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Arrowhead Pharma's volatility:

Historical Volatility

This type of stock volatility measures Arrowhead Pharma's fluctuations based on previous trends. It's commonly used to predict Arrowhead Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Arrowhead Pharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Arrowhead Pharma's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Arrowhead Pharma Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
.

Arrowhead Pharma Projected Return Density Against Market

Given the investment horizon of 90 days Arrowhead Pharma has a beta of 0.229 . This suggests as returns on the market go up, Arrowhead Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arrowhead Pharma will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arrowhead Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arrowhead Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arrowhead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Arrowhead Pharma is significantly underperforming DOW.
   Predicted Return Density   
       Returns  
Arrowhead Pharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how arrowhead stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Arrowhead Pharma Price Volatility?

Several factors can influence a Stock's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Arrowhead Pharma Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arrowhead Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arrowhead Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arrowhead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Arrowhead Pharma is 36819.02. The daily returns are distributed with a variance of 13.77 and standard deviation of 3.71. The mean deviation of Arrowhead Pharma is currently at 3.06. For similar time horizon, the selected benchmark (DOW) has volatility of 1.12
α
Alpha over DOW
-0.08
β
Beta against DOW0.23
σ
Overall volatility
3.71
Ir
Information ratio -0.0018

Arrowhead Pharma Stock Return Volatility

Arrowhead Pharma historical daily return volatility represents how much of Arrowhead Pharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 3.7105% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 1.1293% risk (volatility on return distribution) over the 90 days horizon.
 Performance (%) 
       Timeline  

About Arrowhead Pharma Volatility

Volatility is a rate at which the price of Arrowhead Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Arrowhead Pharma may increase or decrease. In other words, similar to Arrowhead's beta indicator, it measures the risk of Arrowhead Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Arrowhead Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 329 people.

Arrowhead Pharma Investment Opportunity

Arrowhead Pharma has a volatility of 3.71 and is 3.28 times more volatile than DOW. 32  of all equities and portfolios are less risky than Arrowhead Pharma. Compared to the overall equity markets, volatility of historical daily returns of Arrowhead Pharma is lower than 32 () of all global equities and portfolios over the last 90 days. Use Arrowhead Pharma to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Arrowhead Pharma to be traded at $42.45 in 90 days.

Significant diversification

The correlation between Arrowhead Pharma and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharma and DJI in the same portfolio, assuming nothing else is changed.

Arrowhead Pharma Additional Risk Indicators

The analysis of Arrowhead Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Arrowhead Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Arrowhead Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Arrowhead Pharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Arrowhead Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Arrowhead Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Arrowhead Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Arrowhead Pharma.
Please continue to Trending Equities. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.